Screener
Avalo Therapeutics AVTX Gross Profit
Discontinued — last reported Q3 '24
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
The source filing: Avalo Therapeutics’s 10-Q, filed November 6, 2025. Open the filing →
- Filed
- Nov 6, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001534120-25-000018
FAQ
- What is Avalo Therapeutics's gross profit?
- Avalo Therapeutics (AVTX) reported gross profit of $963K in Q3 2024.
- How has Avalo Therapeutics's gross profit changed year-over-year?
- Avalo Therapeutics's gross profit increased by 8854.5% year-over-year, from -$11K to $963K.
- What is the long-term trend for Avalo Therapeutics's gross profit?
- Over 2 years (2021 to 2023), Avalo Therapeutics's gross profit has grown at a -60.5% compound annual growth rate (CAGR), from $4.11M to $640K.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Avalo Therapeutics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude